Specific inhibition of macrophage TNF-α expression by in vivo ribozyme treatment

Journal of Immunology

Volumn 163, Issue 4, 1999, Pages 2008-2016

  Kisich, Kevin O ^a,c   Malone, Robert W ^a,d   Feldstein, Paul A ^b   Erickson, Kent L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Molecular Design   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RIBOZYME; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME MECHANISM; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TARGET CELL;

ANIMALS; ASCITIC FLUID; BASE SEQUENCE; CATIONS; CELLS, CULTURED; FEMALE; HYDROLYSIS; INJECTIONS, INTRAPERITONEAL; KINETICS; LIPIDS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PERITONEUM; PHOSPHATIDYLETHANOLAMINES; QUATERNARY AMMONIUM COMPOUNDS; RNA, CATALYTIC; RNA, MESSENGER; SPERMINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033566954     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Masahiro, H., N. Higashi, H. Taki, and T. Osawa. 1990. Cytolytic mechanisms of activated macrophages. J. Immunol. 144:1425.
2. Waage, A., and A. O. Aasen. 1992. Different role of cytokine mediators in septic shock related to meningococcal disease and surgery/polytrauma. Immunol. Rev. 127:220.
3. Torti, F. M., B. Dieckmann, B. Beutler, A. Cerami, and G. M. Ringold. 1985. A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science 229:867.
4. Feldmann, M, F. M. Brennan, R. O. Williams, A. P. Cope, D. L. Gibbons, P. D. Katsikis, and R. N. Maini. 1992. Evaluation of the role of cytokines in autoimmune disease: the importance of TNF α in rheumatoid arthritis. Prog. Growth Factor Res. 4:247.
5. Sharief, M. K., and E. J. Thompson. 1992. In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosis. J. Neuroimmunol. 38:27.
6. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869.
7. Maini, R. N., F. M. R. Brennan, C. Q. Williams, A. P. Chu, D. Cope, M. Gibbons, M. Elliott, and M. Feldmann. 1993. TNF-α in rheumatoid arthritis and prospects of anti-TNF therapy. Clin. Exp. Rheumatol. Suppl. 8:S173.
8. Been, M. D., and T. R. Cech. 1986. One binding site determines sequence specificity of Tetrahymena pre-rRNA self-splicing, trans-splicing, and RNA enzyme activity. Cell 47:207.
9. Prasad, Y., J. B. Smith, P. A. Gottlieb, J. Bentz, and G. Dinter-Gottlieb. 1992. Deriving a 67-nucleotide trans-cleaving ribozyme from the hepatitis delta virus antigenomic RNA. Antisense Res. Dev. 2:267.
10. Collins, R. A., and J. E. Olive. 1993. Reaction conditions and kinetics of self-cleavage of a ribozyme derived from Neurospora VS RNA. Biochemistry 32: 2795.
11. Haseloff, J., and W. L. Gerlach. 1988. Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334:585.
12. Feldstein, P. A., and G. Breuning. 1993. Catalytically active geometry in the reversible circularization of "mini-monomer" RNAs derived from the complimentary strand of tobacco ringspot virus satellite RNA. Nucleic Acids Res. 21: 1991.
13. Sioud, M., J. B. Natvig, and O. Forre. 1992. Preformed ribozyme destroys tumor necrosis factor mRNA in human cells. J. Mol. Biol. 223:831.
14. Heidenreich, O., and F. Eckstein. 1992. Hammerhead ribozyme-mediated cleavage of the long terminal repeat RN A of human immunodeficiency virus type 1. J. Biol. Chem. 267:1904.
15. Chen, S., C. S. Song, Y. Lavrovsky, B. Bi, R. Vellanoweth, B. Chatterjee, and A. K. Roy. 1998. Catalytic cleavage of the androgen receptor messenger RNA and functional inhibition of androgen receptor by a hammerhead ribozyme. Mol. Endocrinol. 12:1558.
16. Kisich, K. O., S. J. Freedland, and K. L. Erickson. 1997. Factors altering ribozyme-mediated cleavage of tumor necrosis factor-α mRNA in vitro. Biochem. Biophys. Res. Commun. 236:205.
17. Malone, R. W., P. L. Felgner, and I. M. Verma. 1989. Cationic liposome-mediated RNA transfection. Proc. Natl. Acad. Sci. USA 86:6077.
18. Beckler, G. 1992. Synthesis of large amounts of RNA using the ribo-max protocol. Promega Notes 39:12.
19. Fischer, E., M. A. Marano, K. J. Van Zee, C. S. Rock, A. S. Hawes, W. A. Thomas, L. DeForge, J. S. Kenney, D. G. Remick, and D. C. Bloedow. 1992. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J. Clin. Invest. 89:1551.
20. Perreault, J. P., D. Labuda, N. Usman, J. H. Yang, and R. Cedergreen. 1991. Relationship between 2′-hydroxyls and magnesium binding in the hammerhead RNA domain: a model for ribozyme catalysis. Biochemistry 30:4020.
21. Takagi, Y., and K. Taira. 1995. Temperature-dependent change in the rate-determining step in a reaction catalyzed by a hammerhead ribozyme. FEBS Lett. 361:273.
22. van de Loosdrecht, A. A., R. H. Beelen, G. J. Ossenkoppele, M. G. Broekhoven, and M. M. Langenhuijsen. 1993. A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia J. Immunol. Methods 174: 311.
23. Brewer, G. 1994. Post-transcriptional considerations of gene expression: translation, mRNA stability, and poly(A) processing. In Gene Therapeutics: Methods and Applications of Direct Gene Transfer. J. A. Wolf, ed. Birkhauser, Boston, MA. pp. 40-59.
24. Crooke, S. T., K. M. Lemonidis, L. Neilson, R. Griffey, E. A. Lesnik, and B. P. Monia. 1995. Kinetic characteristics of Escherichia coli RNase HI: cleavage of various antisense oligonucleotide-RNA duplexes. Biochen. J. 312:599.
25. Sioud, M. 1996. Ribozyme modulation of lipopolysaccharide-induced tumor necrosis factor-α production by peritoneal cells in vitro and in vivo. Eur. J. Immunol. 26:1026.
26. Perriman, R., L. Graf, and W. L. Gerlach. 1993. A ribozyme that enhances gene suppression in tobacco protoplasts. Antisense Res. Dev. 3:253.
27. Semon, D., E. Kawashima, C. V. Jongeel, A. N. Sakhov, and S. A. Nedospasov. 1987. Nucleotide sequence of the murine TNF locus, including the TNF-α (tumor necrosis factor) and TNF-β (lymphotoxin) genes. Nucleic Acids Res. 15:9083.
28. Tsuchihashi, Z., M. Khosla, and D. Herschlag. 1993. Protein enhancement of hammerhead ribozyme catalysis. Science 262:99.
29. Hough, R.F., and B. L. Bass. 1994. Purification of the Xenopus laevis double-stranded RNA adenosine deaminase. J. Biol. Chem. 269:9933.
30. James, B. D., G. J. Olsen, J. Liu, and N. R. Pace. 1988. The secondary structure of ribonuclease P RNA, the catalytic element of a ribonucleoprotein enzyme. Cell 52:19.
31. Collart, M. A., D. Belin, J. Vassali, S. de Kossodo, and P. Vassali. 1986. γ-Interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164:2113.
32. Brewer, G., and J. Ross. 1988. A shortening and degradation of the 3′ AU-rich sequences of human c-myc mRNA in a cell-free system. Mol. Cell. Biol. 8:1697.
33. Stein-Elroy, O., T. R. Fuerst, and B. Moss. 1989. Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5′ sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc. Natl. Acad. Sci. USA 86:6126.